KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Long-Term Debt Issuances (2016 - 2025)

Astrana Health's Long-Term Debt Issuances history spans 10 years, with the latest figure at $707.3 million for Q3 2025.

  • For Q3 2025, Long-Term Debt Issuances rose 45385.53% year-over-year to $707.3 million; the TTM value through Sep 2025 reached $1.1 billion, up 145.24%, while the annual FY2024 figure was $171.9 million, 39.59% down from the prior year.
  • Long-Term Debt Issuances for Q3 2025 was $707.3 million at Astrana Health, up from $412.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $707.3 million in Q3 2025 and bottomed at -$1.7 million in Q3 2023.
  • The 5-year median for Long-Term Debt Issuances is $1.6 million (2022), against an average of $117.3 million.
  • The largest annual shift saw Long-Term Debt Issuances crashed 331.51% in 2023 before it skyrocketed 51455.56% in 2024.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $569000.0 in 2021, then skyrocketed by 183.3% to $1.6 million in 2022, then surged by 17550.56% to $284.5 million in 2023, then tumbled by 99.45% to $1.6 million in 2024, then skyrocketed by 45385.53% to $707.3 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Long-Term Debt Issuances are $707.3 million (Q3 2025), $412.0 million (Q1 2025), and $1.6 million (Q3 2024).